Pediatric Clinical Trial
Official title:
A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children With Hereditary Angioedema Who Are 2 to < 12 Years of Age
The purpose of this study is to evaluate the pharmacokinetics (PK) and safety of berotralstat to determine the appropriate weight-based dose for pediatric participants 2 to < 12 years old for prophylactic treatment to prevent attacks of hereditary angioedema (HAE).
This is a single-arm, open-label study designed to evaluate the PK and safety of berotralstat weight-based treatment for the prevention of hereditary angioedema attacks in pediatric participants 2 to < 12 years of age. This study will consist of two treatment periods: a 12-week standard-of-care (SOC) treatment period followed by an open-label berotralstat treatment period lasting up to 144 weeks. Participants will be enrolled into 4 dose cohorts; participant weight will be used to determine assignment to each cohort with the higher weight cohorts (Cohorts 1 and 2) enrolling first and in parallel. Safety assessments and PK modelling from all available PK data will then be used to confirm the weight bands for sequentially enrolling Cohorts 3 and 4.The effectiveness of berotralstat in this population will be summarized using descriptive statistical methods. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
| Completed |
NCT01981954 -
A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)
|
Phase 3 | |
| Completed |
NCT02199626 -
SECOND GENERATION COLON CAPSULE ENDOSCOPY (CCE-2) IN PEDIATRIC CROHN'S DISEASE (CD).
|
Phase 4 | |
| Recruiting |
NCT04679792 -
Postual Control in Pediatric Chiari I Malformation
|
||
| Recruiting |
NCT06061159 -
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
|
Phase 4 | |
| Not yet recruiting |
NCT02182648 -
Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction
|
Phase 4 | |
| Active, not recruiting |
NCT04176640 -
Quantifying Brain Injury on Computed Tomography in Hospitalized Children
|
||
| Active, not recruiting |
NCT06146452 -
Micronutrient Status in Pediatric Palliative Care
|
||
| Completed |
NCT04041180 -
Impact on the Length of Stay in Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: .
|
||
| Not yet recruiting |
NCT06165003 -
Examination of Nurses' Use of Broselow Tape in Non-resuscitation Pediatric Emergency Department Practices
|
N/A | |
| Recruiting |
NCT02286297 -
Pediatric Endotracheal Intubation During Resuscitation
|
N/A | |
| Unknown status |
NCT00613184 -
Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses
|
N/A | |
| Recruiting |
NCT00265772 -
Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis
|
Phase 4 | |
| Completed |
NCT04106063 -
A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children
|
||
| Not yet recruiting |
NCT06376643 -
Augmented Reality to Support Cardiopulmonary Resuscitation
|
N/A | |
| Not yet recruiting |
NCT05511233 -
ERAS Protocol in Newborns: CARES Study
|
N/A | |
| Not yet recruiting |
NCT04127968 -
Efficacy and Safety of Vitamin A Treatment for Children With Sepsis
|
N/A | |
| Active, not recruiting |
NCT04472286 -
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
|
||
| Recruiting |
NCT05909878 -
Virtual Reality Distraction for Anxiety (VR-IMAGINE at HSJ)
|
N/A | |
| Recruiting |
NCT04988516 -
Virtual Reality Distraction for Anxiety (VR-IMAGINE)
|
N/A |